SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9818	Companies
197007	Keywords
128065	Articles
104767	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 06/02/2025 at 07:05, 8 months 4 days ago

Sanofi va acquérir Blueprint Medicines pour 9,5 milliards de dollars

Maladies Rares Acquisition De Sanofi Médicaments Blueprint Pipeline D'immunologie Mastocytose Systémique
BRIEF

published on 06/02/2025 at 07:05, 8 months 4 days ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
PRESS RELEASE

published on 06/02/2025 at 07:00, 8 months 4 days ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 8 months 7 days ago

L'itepekimab atteint son critère d'évaluation principal dans l'étude de phase 3 sur la BPCO

Sanofi BPCO Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/30/2025 at 07:05, 8 months 7 days ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1
PRESS RELEASE

published on 05/30/2025 at 07:00, 8 months 7 days ago

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
Itepekimab met primary endpoint in AERIFY-1 study for COPD, with significant reduction in exacerbations. AERIFY-2 did not meet endpoint. Sanofi and Regeneron assessing data for next steps

Sanofi COPD Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/29/2025 at 14:35, 8 months 7 days ago

Impact positif de Beyfortus sur les hospitalisations dues au VRS

Efficacité Santé Publique Beyfortus Hospitalisations VRS Vaccination Infantile
BRIEF

published on 05/29/2025 at 14:35, 8 months 7 days ago

Positive impact of Beyfortus on hospitalizations due to RSV

Public Health Efficiency Beyfortus VRS Hospitalizations Childhood Vaccination
PRESS RELEASE

published on 05/29/2025 at 14:30, 8 months 7 days ago

Communiqué de presse : L’avantage de Beyfortus pour la santé publique renforcé par la première comparaison en situation réelle des programmes de vaccination infantile et maternelle contre le VRS
Beyfortus renforce la protection contre le VRS chez les nourrissons avec des taux d'efficacité élevés et durables, confirmés par une étude en situation réelle. Des données présentées à l'ESPID 2025 démontrent une réduction significative des hospitalisations

Efficacité VRS Étude Beyfortus Hospitalisations
PRESS RELEASE

published on 05/29/2025 at 14:30, 8 months 7 days ago

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Real-world comparison shows Beyfortus and RSVpreF immunization programs reduce infant RSV hospitalizations in Spain and UK. Beyfortus provides sustained protection against RSV with high efficacy and safety profile

RSV Beyfortus RSVpreF Infant Immunization

Accesswire

Published on 02/06/2026 at 13:30, 9 minutes ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 13:00, 39 minutes ago

Revolve Announces US$40 Million Strategic Financing With Callaway Capital
Published on 02/06/2026 at 08:00, 5 hours 39 minutes ago

Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 03:50, 9 hours 49 minutes ago

High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 10 hours 54 minutes ago

High Tide Resources annonce des placements privés sans courtier

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 12:47, 52 minutes ago

EQS-Adhoc: NAKIKI SE requests change of auditor for the 2024 financial year
Published on 02/06/2026 at 12:41, 58 minutes ago

EQS-Adhoc: ecotel communication ag: Preliminary 2025 Financial Figures; Operating EBITDA below guidance
Published on 02/06/2026 at 12:35, 1 hour 4 minutes ago

Hoymiles Launches HiOne All-in-One Residential Storage to Set New Industry Benchmark for Smart Home Energy Independence
Published on 02/06/2026 at 12:25, 1 hour 14 minutes ago

World's Best Tactical Police Units Converge at UAE SWAT Challenge 2026
Published on 02/06/2026 at 11:45, 1 hour 53 minutes ago

Le Conseil d’administration de Sartorius Stedim Biotech S.A. approuve une proposition de dividende de 0,69 euro

Les Echos

Published on 02/06/2026 at 07:54, 5 hours 44 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
Published on 02/05/2026 at 19:24, 18 hours 14 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 18 hours 14 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 18 hours 24 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 18 hours 24 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026

View all LES ECHOS COMFI WIRE